The National Science Foundation (NSF) estimates that U.S. research and development (R&D) funding reached an all-time high of $499.3 billion in 2015 – an increase of approximately $21.6 billion over 2014 levels ($477.7 billion). The $21.6 billion increase marks the third time in three years that overall U.S. R&D funding grew by more than $20 billion – $20.4 billion in 2013 and $21.1 billion in 2014.

While some researchers contend that university-industry collaboration may corrupt the academic ideal of open sciences and reduce academic productivity, researchers from the London Business School (LBS) and University of Southern California (USC) found that university-industry research collaborations – in certain situations – can lead to more publications but fewer patents than similar academic studies without industry partners. These findings would indicate that such collaboration can actually stimulate open science and increase academic productivity, rather than weaken it.

The U.S. House Science Committee released a letter last week reasserting the majority party’s interest in setting R&D priorities for federal science agencies and supporting appropriation levels that generally align with the White House’s budget blueprint. The letter notes priorities for most of the $42 billion in R&D budgets within the committee’s purview.

In part one of two, SSTI will examine NIH’s proposed changes that will place limits on individual researcher funding.

On May 2, the National Institutes of Health (NIH) announced that it intends to implement a new approach to grant funding with the purpose of increasing the number of researchers receiving grants. These proposed changes are due to a highly skewed distribution of NIH funding with 10 percent of NIH-funded investigators receiving over 40 percent of funding. NIH intends to roll out specific policies and procedures as part of the new approach – titled the Grant Support Index (GSI) – that will assess effectiveness of NIH research investments. During this time, NIH also will seek feedback from on how best to implement the individual grant funding limits.

U.S. companies spent 18 percent of their research and development dollars outside of the United States in 2013, according to data recently released by the NSF. The $73 billion in foreign R&D is concentrated in the information industry, pharmaceuticals, semiconductors, and automobiles and parts. Those four industries accounted for 52 percent of all foreign R&D performance by U.S.

State and local governments invested $3.8 billion in R&D at institutions of higher education in FY 2015, with the top ten states accounting for $2.3 billion – roughly 59.4 percent of overall spending, according to an SSTI analysis of NSF data. From FY 2011 to FY 2015, total spending remained relatively unchanged (0.1 percent decrease). Over that same period, colleges and universities in 25 states reported increased expenditures from state governments, while 25 and the District of Columbia reported declines.

When the U.S. government made their R&D tax credit permanent in December 2015, it made a long-term commitment to using incentives to entice private firms to invest in research and development, joining many countries around the world. Although most studies find that R&D tax incentives promote R&D, there is little consensus on the extent of this effect. A recent firm-level analysis from the United Kingdom finds some of the strongest evidence to date on the effectiveness of R&D tax credits in incentivizing innovation. At the same time, however, other studies suggest other elements of a national economy such as education and infrastructure may be more important.

U.S. companies continue to emphasize innovation, as private performance of R&D increased for the fourth consecutive year, according to recently released data from the National Science Foundation. In total, U.S. businesses performed 6.7 percent more R&D in 2013 than in 2012, according to the data, and nearly 19 percent more R&D from 2010 to 2013. Combined, the top 10 states performed approximately two-thirds (65.3 percent) of all private research and development in the United States, led by California, whose $89.4 billion in corporate R&D performance accounted for 27.7 percent of the national total.

The National Science Foundation tells of a record number of doctorates awarded at the same time the American Association of University Professors (AAUP) reports opportunities to secure tenure-track positions continue to shrink, the State Higher Education Executive Officers Association points out state support for higher education remain

As the 2015-2016 academic year comes to a close, universities and their industry partners have announced several new university-industry partnerships to leverage university research capabilities to address industry needs. Fortune 500 companies including IBM, Rolls-Royce, and several pharma companies have agreed to commit millions of dollars to support these partnerships targeted at increasing the pace of scientific discovery as well as training the next generation of STEM professionals.

In 2011, U.S.-located companies spent $29.6 billion for extramural (purchased and collaborative) research and development performed by mostly domestic organizations, according to a National Science Foundation (NSF) InfoBrief. Approximately $24 billion in R&D spending was purchased R&D. The additional $5.6 billion was payments to R&D collaborators.

About 70 percent of 2011 U.S. business R&D spending occurred in 10 states, according to a report from the National Center for Science and Engineering Statistics (NCSES). California leads the country in overall business R&D, and nearly every top industry.  Both the San Jose-San Francisco-Oakland and Los Angeles-Long Beach area rank in the top three areas for business research.  Other top states include Washington, with high spending on software R&D, and Texas, a leader in semiconductor and mining research.

Most R&D expenditures are concentrated across just a handful of states, according to recent NSF data on how research and development is funded in the United States.  In 2011, nearly two-thirds of all research and development expenditures came from private sources. In the wake of the nation’s federal stimulus package that saw an upswing in government spending on research and development, most states are beginning to rely more on innovation that stems from R&D conducted and paid for by private sources rather than the federal government.

The Maryland Technology Development Corporation (TEDCO) announced that it received state-backing for its Cybersecurity Investment Fund (CIF) – a fund that helps companies across the state develop and commercialize new cybersecurity products. TEDCO will make investments of up to $100,000 to help companies achieve early technical milestones that are critical to the commercialization process.